Cite
HARVARD Citation
Visco, C. et al. (2017). Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi. Lancet. 4 (1), pp. e15-e23. [Online].